A detailed history of Mount Yale Investment Advisors, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 6,636 shares of NTRA stock, worth $1.17 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
6,636
Previous 7,529 11.86%
Holding current value
$1.17 Million
Previous $956,000 9.83%
% of portfolio
0.09%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

SELL
$117.67 - $174.0 $105,079 - $155,382
-893 Reduced 11.86%
6,636 $1.05 Million
Q3 2024

Oct 23, 2024

SELL
$97.75 - $129.67 $483,276 - $641,088
-4,944 Reduced 39.64%
7,529 $956,000
Q2 2024

Aug 13, 2024

SELL
$85.28 - $112.6 $405,165 - $534,962
-4,751 Reduced 27.58%
12,473 $1.35 Million
Q1 2024

May 15, 2024

SELL
$59.21 - $92.9 $235,063 - $368,813
-3,970 Reduced 18.73%
17,224 $1.58 Million
Q4 2023

Feb 12, 2024

BUY
$37.55 - $62.64 $165,295 - $275,741
4,402 Added 26.21%
21,194 $1.33 Million
Q3 2023

Oct 11, 2023

BUY
$43.4 - $62.52 $77,078 - $111,035
1,776 Added 11.83%
16,792 $743,000
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $894 - $1,048
19 Added 0.13%
15,016 $730,000
Q1 2023

May 11, 2023

BUY
$36.57 - $58.29 $181,204 - $288,826
4,955 Added 49.34%
14,997 $832,000
Q4 2022

Feb 13, 2023

SELL
$34.17 - $47.91 $43,259 - $60,654
-1,266 Reduced 11.2%
10,042 $403,000
Q3 2022

Nov 07, 2022

BUY
$36.93 - $56.68 $417,604 - $640,937
11,308 New
11,308 $496,000
Q3 2021

Nov 02, 2021

SELL
$100.17 - $126.36 $194,530 - $245,391
-1,942 Closed
0 $0
Q2 2021

Aug 04, 2021

BUY
$86.05 - $119.72 $167,109 - $232,496
1,942 New
1,942 $220,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $17.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Mount Yale Investment Advisors, LLC Portfolio

Follow Mount Yale Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mount Yale Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mount Yale Investment Advisors, LLC with notifications on news.